Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Stock Information | RedChip

Fennec Pharmaceuticals Inc. (NASDAQ: FENC)


$6.1900
N/A ( +0.65% ) 44.1K

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Market Data


Open


$6.1900

Previous close


$6.1900

Volume


44.1K

Market cap


$169.81M

Day range


$5.9610 - $6.2750

52 week range


$3.9600 - $11.9200

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 29, 2023
4 Insider transactions 1 Dec 28, 2023
8-k 8K-related 18 Dec 06, 2023

Latest News